JavaScript is currently not supported/disabled by this browser. Please enable JavaScript for full functionality.

Call Us 1 - 866 - 986 - 9598
[email protected]

Sign Up

Login
- My Order
- Return Requests
- Track my Order

Home / Cells / Primary Cells

Human Cord Blood CD34+ Progenitor Cells, Pooled

SKU : BHC18000596

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Request More Infos

AcceGen Biotech

view supplier details

Order Now

Credit card payments now incur a 3% fee.

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Ask Merchant

Request More Infos

Sample Request

Mfr.No.	ABC-TC3576
Description	CD34 is a well-known marker for primitIVe and bone marrow-derIVed progenitor cells, especially for hematopoietic and endothelial progenitors. AcceGen offers CD34+ progenitor cells in a phenotypically undifferentiated state. The progenitor cells are derIVed from cord blood of healthy donors and produced at the AcceGen facility. Progenitor cells contain two main cellular subpopulations, hematopoietic and endothelial progenitor cells. CD34+ progenitor cells are suitable for a series of studies for directed differentiation into more committed types of blood cells and endothelial lineages. Immediately after isolation, the freshly prepared CD34+ progenitor cells are cryopreserved using a serum-free freezing medium.Samples from each donor are tested VIa PCR to confirm non-reactIVIty.Cord blood CD133+ cells are isolated using direct positIVe immunomagnetic selection for CD133+ cells. The majority of CD133+ cells also eXpress CD34. CD133 is a glycoprotein with sub-cellular localization in plasma membrane protrusions. In humans, this protein was originally identified as an antigenic marker eXpressed on hematopoietic stem cells. In addition, these cells are highly proliferatIVe primitIVe hematopoietic progenitors. They can gIVe rise to mature terminally differentiated hematopoietic cells by means of directed differentiation.AcceGen offers CD133 cells in a phenotypically undifferentiated state. The cells are derIVed from fresh cord blood of healthy donors and produced at the AcceGen facility. Immediately after isolation, the freshly prepared CD133 cells are cryopreserved using a serum-based cryopreservation medium. Each VIal contains 100,000 cells per VIal.
Categories	Primary Cells
Species	Human
Applications	For research use only

Shipping	Dry Ice
Storage	Liquid Nitrogen
Quality Control	All cells test negatIVe for mycoplasma, bacteria, yeast, and fungi.

Have you used this product?

Rate it now..!!

Login to Review

SKU	Supplier No.	Your price	Quantity
BHC18000596	ABC-TC3576	-		Add to Quote

ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.

© 2024 Biohippo. All rights reserved.